CytoSorbents Achieves Record Revenue and Product Sales Growth in 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq rise as tech stocks gain ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Cytosorbents Corporation (NASDAQ: CTSO) | Delayed: 4.25 +0.13 (3.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.12 | 52 Week High | $7.48 | |||
| Open | $4.08 | 52 Week Low | $3.11 | |||
| Day High | $4.67 | P/E | N/A | |||
| Day Low | $4.08 | EPS | $-0.03 | |||
| Volume | 16,193 | |||||
